77 related articles for article (PubMed ID: 2893420)
1. Behavioral and neurochemical characteristics of stimulant-induced augmentation.
Segal DS; Kuczenski R
Psychopharmacol Bull; 1987; 23(3):417-24. PubMed ID: 2893420
[No Abstract] [Full Text] [Related]
2. Proceedings: Effect of chronic treatment with central stimulants on brain monoamines and some behavioural and physiological functions in rats, guinea pigs, and rabbits.
Lewander T
Psychopharmacol Bull; 1974 Jul; 10(3):11-2. PubMed ID: 4153705
[No Abstract] [Full Text] [Related]
3. Neurochemical mechanisms in rat behavioral models of the euphorigenic and antihyperkinetic actions of psychomotor stimulant drugs.
Hill RT
Psychopharmacol Bull; 1975 Jul; 11(3):37-8. PubMed ID: 239434
[No Abstract] [Full Text] [Related]
4. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
[TBL] [Abstract][Full Text] [Related]
5. Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice.
Ago Y; Nakamura S; Kajita N; Uda M; Hashimoto H; Baba A; Matsuda T
Synapse; 2007 Sep; 61(9):757-63. PubMed ID: 17568413
[TBL] [Abstract][Full Text] [Related]
6. Functional imaging and neurochemical correlates of stimulant self-administration in primates.
Howell LL; Wilcox KM
Psychopharmacology (Berl); 2002 Oct; 163(3-4):352-61. PubMed ID: 12373436
[TBL] [Abstract][Full Text] [Related]
7. Progress report from the testing program for stimulant and depressant drugs (1993).
Patrick GA; Harris LS; Woolverton WL; Nader MA; Winger G; Woods JH
NIDA Res Monogr; 1994; 140():248-63. PubMed ID: 8722467
[No Abstract] [Full Text] [Related]
8. Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-1B (PDE1B) enzyme.
Siuciak JA; McCarthy SA; Chapin DS; Reed TM; Vorhees CV; Repaske DR
Neuropharmacology; 2007 Jul; 53(1):113-24. PubMed ID: 17559891
[TBL] [Abstract][Full Text] [Related]
9. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
[TBL] [Abstract][Full Text] [Related]
10. Behavioral and neurochemical sensitization to amphetamine following early postnatal administration of methylmercury (MeHg).
Wagner GC; Reuhl KR; Ming X; Halladay AK
Neurotoxicology; 2007 Jan; 28(1):59-66. PubMed ID: 16942796
[TBL] [Abstract][Full Text] [Related]
11. Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: a review and synthesis.
Solanto MV
Psychol Bull; 1984 May; 95(3):387-409. PubMed ID: 6152684
[No Abstract] [Full Text] [Related]
12. Correlation of behavioral and EEG effects during interaction studies with secobarbital and psychomotor stimulants.
Killam KF; Slikker W; Brocco MJ; Gehrmann JE
Proc West Pharmacol Soc; 1976; 19():432-4. PubMed ID: 11504
[No Abstract] [Full Text] [Related]
13. [Pharmacologic study of 11-dimethylaminopropylidene 6H dibenz (b,e) oxepine].
Cahen R
C R Seances Soc Biol Fil; 1969 Feb; 162(7):1331-6. PubMed ID: 4388838
[No Abstract] [Full Text] [Related]
14. Behavioral and biochemical responses to d-amphetamine in MCH1 receptor knockout mice.
Smith DG; Qi H; Svenningsson P; Wade M; Davis RJ; Gehlert DR; Nomikos GG
Synapse; 2008 Feb; 62(2):128-36. PubMed ID: 18000809
[TBL] [Abstract][Full Text] [Related]
15. Evidence that the 5-HT1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects.
Carey RJ; DePalma G; Damianopoulos E; Shanahan A; Müller CP; Huston JP
Brain Res; 2005 Feb; 1034(1-2):162-71. PubMed ID: 15713268
[TBL] [Abstract][Full Text] [Related]
16. Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder.
Augustyniak PN; Kourrich S; Rezazadeh SM; Stewart J; Arvanitogiannis A
Behav Brain Res; 2006 Feb; 167(2):379-82. PubMed ID: 16246436
[TBL] [Abstract][Full Text] [Related]
17. Methylphenidate (Ritalin): behavioral studies in the rat.
Askenasy EP; Taber KH; Yang PB; Dafny N
Int J Neurosci; 2007 Jun; 117(6):757-94. PubMed ID: 17454243
[TBL] [Abstract][Full Text] [Related]
18. Proceedings: Drug-induced stereotyped behavior: similarities and differences.
Wallach MB
Psychopharmacol Bull; 1974 Jul; 10(3):12-3. PubMed ID: 4153704
[No Abstract] [Full Text] [Related]
19. The effects of FK506, a specific calcineurin inhibitor, on methamphetamine-induced behavioral change and its sensitization in rats.
Tsukamoto T; Iyo M; Tani K; Sekine Y; Hashimoto K; Ohashi Y; Suzuki K; Iwata Y; Mori N
Psychopharmacology (Berl); 2001 Nov; 158(2):107-13. PubMed ID: 11702083
[TBL] [Abstract][Full Text] [Related]
20. [Neurotropic properties of aminooxyacetic acid and gamma-aminooxybutyric acid].
Ostrovskaia RU; Artemenko GN; Raevskii KS
Farmakol Toksikol; 1970; 33(2):137-42. PubMed ID: 4393231
[No Abstract] [Full Text] [Related]
[Next] [New Search]
